Premium
PROGNOSTIC VALUE OF THE INTERVAL BETWEEN RELAPSE AND THERAPY INITIATION IN DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS. ANALYSIS FROM THE CZECH LYMPHOMA STUDY GROUP DATABASE
Author(s) -
Janikova A.,
Chloupkova R.,
Campr V.,
Kopalova N.,
Klener P.,
Benesova K.,
Hamouzova J.,
Belada D.,
Sykorova A.,
Prochazka V.,
Pirnos J.,
Duras J.,
Mocikova H.,
Michalka J.,
Trneny M.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.83_2631
Subject(s) - medicine , lymphoma , diffuse large b cell lymphoma , b symptoms , clinical trial , biopsy , surgery